News | March 13, 2024
             
           Nirma acquires majority stake in Glenmark Life Sciences
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
 
        Subscribe To Our Newsletter & Stay Updated